The company was not sold, it was liquidated of its assets. The 2 judges said it. The monitor said it. The monitor's lawyer said it, The buyer said it. The buyer's lawyer said it. The board approved it before they resigned. Oh well.
The contract with Vinmar died when the plant was sold, despite the shareholders thinking it could be enforced without the ability to make the product it required. The way that BioAmber was running the business at a loss, they'd have spent $4B to sell the $3B of product.
Shouldn't be surprising that LCYB is running the plant better than BioAmber did.
I swear I’ll never use the phrase “you can’t make this stuff up” ever again after being on the OTC. Apparently you can.